ISSCA Launches New Board Aimed at Connecting Professionals in Regenerative Medicine
The society’s board helps scientists and physicians in the field make connections to improve research and provide safer and more effective patient care
MIAMI LAKES, Florida— The International Association for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced the launch of a new online board that will help to promote the organization’s goal of facilitating the interchange of information, research, and training between physicians and scientists across the globe.
The launch of the new board comes on the heels of ISSCA’s recent announcement of a new leadership team for the society, which has recognized the importance of more easily facilitating global connections between scientists and physicians working to use stem cell research, technology, and science to better human lives.
The board, located on ISSCA’s webpage at https://www.issca.us, serves as a one-stop location for practitioners in the field of stem cell research and technology to find other practitioners across the globe and easily make connections in order to help grow their professional network, exchange best practices and research, improve standards of quality, and standardized treatment protocols in this fast-growing area of medicine that is still in its infancy.
Because regenerative medicine is a new area of medicine, physicians and scientists in the field are largely self-taught without adherence to any standards. ISSCA’s goal is to act as a resource to this burgeoning field and to help practitioners receive proper training and to standardize treatment protocols in an effort to deliver safer and more effective treatments to patients. The launch of the new board will help the society further reach this goal.
Professionals practicing regenerative medicine are encouraged to become members of the society to help assure proper training in the field and compliance with international protocols. Membership into the society will allow practitioners to be featured in the new board and have access to valuable research to standardize their knowledge, access opportunities to become certified in the field, attend professional conferences, and network with other professionals with the same interests of improving the field of regenerative medicine.
To learn more about ISSCA and the view the newly launched board, visit https://www.issca.us/
About ISSCA:
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com
- Published in News
ISSCA Announces Global Venues for the 6th Annual Regenerative Medicine Symposium
The Symposium will bring the latest trends, developments and commercialization opportunities from the field of regenerative medicine.
(January 9, 2019) – The International Association for Stem Cell Application (ISSCA) is pleased to announce the venues for its 6th Annual Symposium – Applications of Cell Therapies in Medicine and Aesthetic Surgery. The first symposium will be held in May in Barcelona, Spain, followed by Santiago, Chile in July, and Buenos Aires, Argentina on August 16-17, 2019. The Symposium will then proceed to the cities of Bangkok, Brussels and Miami.
The 2019 edition of ‘Applications of Cell Therapies in Medicine and Aesthetic Surgery’ in regenerative medicine promises to be as exciting as the previous edition. The event will focus on the regenerative medicine field, promising therapies for newer and wider spectrum of diseases and medical conditions and how to accommodate them.
Attendees at the 2019 ISSCA Symposium will be introduced to various aspects of stem cell and regenerative medicine solutions through rigorous scientific discussions and Q&A sessions. The topics covered will include:
- Latest trends in stem cell research
- International regulations on managing research and clinical applications
- Applications, product development and commercialization related to stem cell and regenerative medicine
- Business opportunities, marketing tools for patient recruitment, challenges and how to overcome them
This year, the Symposium will bring together students from the global medical community, renowned and well known experts and international speakers from the fields of stem cell research and regenerative medicine. Some of the organizations represented include the Global Stem Cells Group, Stem Cell Center Buenos Aires, Chilean Association of Tissue Engineering and Shockwaves ACHITOC, Investigaciones Artroscopicas SA, Argentine Arthroscopy Association, and Boston Médical Group Spain.
ISSCA’s mission is to support the paradigm shift taking place in healthcare in the 21st century, which is moving from traditional to regenerative medicine. The Symposium is part of its efforts to share and spread the most up to date information on the current advances and cutting-edge developments taking place in stem cell research and regenerative medicine.
The 2018 editions of the Symposium were held at Buenos Aires, Istanbul and Caracas, Venezuela, and were a runaway success. The Buenos Aires event was attended by over 350 physicians from around the world, and over 200 physicians attended the other two editions. The enthusiastic participation has motivated ISSCA to host the event in Buenos Aires for the next consecutive six years.
To learn more about the ISSCA Buenos Aires symposium and to reserve a seat, please visit the stemcellconference.org website, email: info@stemcellsgroup.com, or call: +1305 560 5337.
Venues for the Barcelona, Santiago and Buenos Aires 2019 ISSCA Symposium:
May 2019
Hotel W Barcelona
Plaça Rosa dels Vents, 1,
Final Passeig de Joan de Borbó
Barcelona, España 08039
July 2019
Sheraton Santiago Hotel and Convention Center
Avda. Santa María 1742
Providencia. Santiago, Chile
August 2019
Sheraton Buenos Aires Hotel and Convention Center
San Martin 1225/1275
Buenos Aires, Argentina 1104
- Published in News
ISSCA Offers Cutting Edge Stem Cell and Regenerative Technologies to Clinical Practices Worldwide.
Regenerative medicine is one of the most fascinating fields in medical science. ISSCA is opening two new education centers in order to keep promoting excellence in the field of regenerative medicine.
The International Society for Stem Cells Applications (ISSCA) is set to open two Regenerative Medicine education centers in Tunisia and Belgium.
With this new development, ISSCA is significantly achieving its objective of bringing together as members and professionals of the science for productive collaborations around the Stem Cell research in all its possible fields. ISSCA has created a platform for physicians to collaborate actively, initiate discussions, share comment and exchange information that may be directly translated to therapeutic applications.
ISSCA’s Stem cells and Regenerative Medicine course provides competency training and certification to allied health professionals involved in the practice of Regenerative Medicine. The courses are designed to sequentially build a knowledge foundation to allow physicians to understand and verbalize basic and advanced scientific concepts pertaining to all aspects of Regenerative Medicine.
ISSCA believes the realm of regenerative medicine offers physicians and patients the most exciting frontier in medicine today, and they strive to make it available to them. Physicians should take ISSCA certification because it offers the advantage of world-class research with the endorsement of prestigious medical schools and clinical enterprise. ISSCA offers physicians the opportunity to learn about new, up to date technologies that are applicable to modern therapeutic approaches like stem cell applications.
As a medical specialty, regenerative medicine standards and certifications are essential; which is why ISSCA offers certification training in cities all over the world. ISSCA physicians learn the skills they need to implement regenerative medicine protocols in their practice. Once the participant completes all the units successfully, he/she receives a certificate of training.
About ISSCA:
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit: https://www.issca.us/ or send an email to infor@stemcellsgroup.com
- Published in News
Which Works Better, Viscosupplementation, or Platelet Rich Plasma?
Understanding Viscosupplementation (Hyaluronic Acid)
Explore the mechanism and benefits of Hyaluronic Acid injections, FDA-approved for knee arthritis treatment but also used off-label for other joints.
Efficacy and Evidence of Viscosupplementation
Highlight the results from systematic reviews and randomized controlled trials supporting the effectiveness of Hyaluronic Acid in reducing pain and improving joint function.
Introduction to Platelet Rich Plasma (PRP) Therapy
Discuss PRP therapy, its composition rich in platelets and growth factors, and its applications beyond arthritis treatment, including tendon injuries and potential uses in other medical fields.
Comparison of Effectiveness: Viscosupplementation vs. PRP
Clinical Studies and Comparative Effectiveness
Summarize findings from studies comparing the efficacy of PRP and Hyaluronic Acid injections in managing arthritis pain and improving joint function.
FDA Approval and Regulatory Status
Regulatory Considerations for Treatment
Discuss the FDA approval status of Hyaluronic Acid for knee arthritis versus the off-label use of PRP, and its implications for treatment options and insurance coverage.
Safety Profile and Cost Comparison
Safety and Economic Considerations
Compare the safety profiles of PRP and Hyaluronic Acid, including risks of infection and cost-effectiveness considerations for patients.
Choosing Between HA and PRP: Factors to Consider
Patient-Specific Decision Making
Guide patients on factors influencing the choice between HA and PRP based on efficacy, safety, regulatory status, and cost.
Conclusion: Selecting the Right Treatment
Summarize the advantages and considerations of both Viscosupplementation (HA) and PRP therapies for arthritis pain management, aiding in informed treatment decisions.
References
Ensure comprehensive citations of systematic reviews, clinical trials, and regulatory information supporting the comparison between HA and PRP therapies.
- Published in Blog
How Regenerative Microneedling Can Help Rejuvenate Skin?
Understanding Microneedling for Acne Scars
Explore how microneedling initiates collagen synthesis and aids in skin healing, particularly effective for treating acne scars.
The Role of Platelet Rich Plasma (PRP) in Skin Rejuvenation
Highlight the benefits of PRP therapy in conjunction with microneedling for enhancing skin regeneration and reducing scars.
Scientific Evidence: Effectiveness of PRP with Microneedling
Study by Department of Dermatology, Venereology, and Leprosy
Discuss findings from studies evaluating the effectiveness and safety of PRP combined with microneedling for acne scar treatment.
Mechanism of Action: How Microneedling Works
Initiating Collagen Synthesis and Healing
Explain the process of microneedling in triggering the body’s healing response through controlled micro-injuries and the delivery of growth factors.
Clinical Results: PRP vs. Distilled Water in Microneedling
Comparative Study Outcomes
Summarize results showing the superior efficacy of PRP compared to distilled water in improving acne scars based on clinical trials.
Patient Testimonials and Success Stories
Real-life Experiences
Share patient success stories and testimonials demonstrating the effectiveness of PRP with microneedling in improving skin texture and reducing scars.
Integrating PRP Therapy into Dermatology Practice
Implementation and Considerations
Guide dermatologists on integrating PRP therapy into their practice for effective acne scar management and patient satisfaction.
Conclusion: Advantages of PRP in Skin Rejuvenation
Summarize the benefits of combining PRP with microneedling as an effective treatment option for patients seeking skin rejuvenation and scar reduction.
References
Ensure comprehensive citations of studies and research supporting the efficacy and safety of PRP with microneedling in dermatological treatments.
- Published in Blog
ISSCA announces the 2019 Regenerative Medicine Certification Calendar
MIAMI, Dec. 4, 2018—The International Society for Stem Cell Application (ISSCA) has released its 2019 regenerative medicine certification training course calendar, with programs scheduled in seven international cities and updated curriculum. ISSCA’s objective in 2019 is to provide enhanced educational qualifications to physicians looking for a new approach to treat patients suffering with chronic pain, severe injury, and degenerative conditions and diseases.
The two-day regenerative medicine training course, which teaches easy-to-follow protocols for harvesting adipose and bone marrow stem cells from patients in a clinical environment, will also feature new treatment basics involving allogeneic compounds including exosomes and other compounds derived from (umbilical) cord blood and amniotic fluid, allowing participating physicians to easily and efficiently add certification in cutting-edge regenerative medicine therapies to their practices.
Participating physicians learn how to harvest and isolate bone marrow and adipose-derived autologous stem cells to use in treating multiple conditions.
The two-day course begins with a four-hour lecture on advances in regenerative medicine. Participating physicians will receive more than 12 hours of hands-on training with live patients in protocols for obtaining stem cells from patients, applications that they can take back to their medical offices or clinics and begin using immediately.
Attendees will also receive 12 protocols in digital format to take with them, and gain knowledge and practical skills to easily add regenerative medicine therapies to their practices.
Physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets and more.
The 2019 ISSCA training course calendar is as follows:
January 18-19, 2019 Miami, Fla. (conducted in Spanish language).
http://cursocelulasmadre.com/entrenamiento-miami-mail/ January 25.26, 2019 Miami, Fla. (Conducted in English language). https://www.stemcelltraining.net/miami-stem-cells-course-adwords/
February 1-2, 2019 Quito, Ecuador
February 8-9, 2019 Buenos Aires, Argentina
February 15-16, 2019, Lima, Peru
Fenruary 22-23, 2019 Bogota, Colombia
March 1-2, 2019 Mexico City, Mexico
https://cursocelulasmadre.com/entrenamiento-cancun-mail/ – needs to be fixed – links to a December date!
March 8-9 Abu Dabhi, UAE
https://www.stemcelltraining.net – not a good link! Please correct
ISSA’s stem cell certification course offers practical, personalized training in stem cell harvesting and isolation procedures. To date, ISSCA has trained more than 2,000 physicians worldwide.
Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.
To learn more about the ISSCA certification training courses and to register to participate, visit the Stem Cells Training website, the email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in News
ISSCA to Host 6th Annual Regenerative Medicine Symposium in Buenos Aires, Argentina Aug. 16-17, 2019
MIAMI, Dec. 18, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host its sixth annual “Applications of Cell Therapies in Medicine and Aesthetic Surgery” regenerative medicine symposium in Buenos Aires, Argentina August 16-17, 2019. The focus of the symposium agenda will be allogeneic compounds—how they have changed the regenerative medicine industry, and how the industry will accommodate the challenges allogeneic therapies present.
The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research.
In 2018, the 5th annual symposium was held in three international cities—Buenos Aires, Istanbul, Turkey and Caracas, Venezuela. Each event exceeded organizers’ expectations both in attendance numbers and active participation. More than 200 physicians from the U.S., South America, Europe, the Middle East and Asia attended the symposiums in Istanbul and Caracas, and more than 350 physicians from around the world attended in Buenos Aires.
The high attendance and enthusiastic participation of attendees at the Argentina symposium, which was held at the Universidad de Buenos Aires, compelled ISSCA organizers to reconsider their multi-country strategy and host the event exclusively in Buenos Aires in 2019. In addition, ISSCA has committed to hosting the annual symposium in Buenos Aires for the next six consecutive years.
In keeping with ISSCA’s commitment to supporting the most current advances in stem cell and regenerative medicine discoveries, the 2019 symposium will explore the impact the acceleration of allogeneic compounds have had on the industry, new challenges they bring to the market, and promising new therapies they are expected to provide to an ever-widening spectrum of diseases and medical conditions.
A group of renowned international speakers, experts in the field of stem cell and regenerative medicine including the latest advances in allogeneic therapies, will lead rigorous scientific discussions and Q&A sessions with physicians in attendance. In Addition, ISSCA has invited representatives from [name of’ lab?], one of the world’s largest regenerative medicine labs to share their experiences and knowledge with physicians representing the global medical community in attendance,
The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells and regenerative medicine solutions.. In addition, business opportunities, industry challenges, and potential strategies for overcoming those challenges will be discussed.
The event venue in Buenos Aires will be announced shortly.
To learn more about the ISSCA Buenos Aires symposium and to reserve a seat, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
- Published in News
